New York, NY, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Osteoarthritis Drug Market by Drug Class (NSAIDs, Corticosteroids, Viscosupplementation Agents, and Others), by Route of Administration (Topical, Parenteral, and Oral), and by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2025”. According to the report, the global osteoarthritis drug market was valued at approximately USD 5,987 million in 2018 and is expected to generate around USD 10,327 million by 2025, at a CAGR of around 8.1% between 2019 and 2025.

Osteoarthritis is a joint degenerative disorder that affects various joint, which mostly affects the elderly population. In osteoarthritis, the smooth gliding surface between joints that provides easy movement is affected with age. This leads to swelling, pain, tenderness, and stiffness in joints and affects the normal movement and quality of life of an individual. There is no permanent cure for this condition. However, medicines help in suppressing the symptoms to a certain extent, thereby offering relief to patients. The medications used for the osteoarthritis treatment mostly include pain relievers, such as Paracetamol, ibuprofen, naproxen, etc. Osteoarthritis affects the knee, shoulder, lower back, etc.

Browse through 55 Tables & 15 Figures spread over 110 Pages and in-depth TOC on “Global Osteoarthritis Drug Market Size 2018: By Type, Industry Share, Trends, Growth, Analysis and Forecast 2025”.

Request Free Sample Report of Global Osteoarthritis Drug Market Report @ https://www.zionmarketresearch.com/sample/osteoarthritis-drug-market

The primary factor likely to drive the global osteoarthritis drug market over the estimated timeframe is the constantly rising aging population. As per the Arthritis Foundation 2017 Report, there were around 30 million Americans suffering from osteoarthritis. Osteoarthritis mostly affects the elderly population. Moreover, increasing research and development activities and innovation of new drugs are also expected to support the growth of the global osteoarthritis drug market over the estimated timeframe. FDA approvals for various drugs are expected to create new growth opportunities in this market. Alternatively, low adoption rate and side effects of these drugs might hamper the growth of the osteoarthritis drug market on a global scale in the future.

The global osteoarthritis drug market is classified into a drug class, route of administration, and distribution channel. By drug class, the osteoarthritis drug market is segmented into corticosteroids, NSAIDs, viscosupplementation agents, and others. Viscosupplementation agents are expected to expand significantly over the forecast time period. By route of administration, this market is segmented into oral, parenteral, and topical. The parenteral segment is expected to dominate this global market over the forecast timespan. The distribution channel segment includes hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies are expected to hold a major market share in the upcoming years.

Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/osteoarthritis-drug-market

North America is expected to dominate the global osteoarthritis drug market in the future, due to the presence of developed economies, such as the U.S. and Canada. These developed economies have better healthcare facilities and infrastructure. Furthermore, most of the market players have their headquarters in this region. Moreover, the increasing prevalence of osteoarthritis, quick FDA approval of drugs pertaining to osteoarthritis, increased funding are some other factors likely to drive the region’s osteoarthritis drug market in the future.

Europe is anticipated to be the second largest region in the osteoarthritis drug market in the upcoming years, owing to the presence of advanced technology and increase in the research and development activities for the development of advanced drugs.

Browse the full “Osteoarthritis Drug Market by Drug Class (NSAIDs, Corticosteroids, Viscosupplementation Agents, and Others), by Route of Administration (Topical, Parenteral, and Oral), and by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018—2025” Report at https://www.zionmarketresearch.com/report/osteoarthritis-drug-market

The Asia Pacific osteoarthritis drug market is the third largest and likely to emerge as the fastest growing over the forecast period, owing to the presence of developing economies, such as India and China. Additionally, there is also an increase in the prevalence of osteoarthritis due to rising geriatric population and constant improvement witnessed related to healthcare facilities and infrastructure in the last couple of years along with an increase in funding of R&D activities and higher adoption of viscosupplementation agents across the region. These are some other factors anticipated to fuel the region’s osteoarthritis drug market in the future.

The Latin American and the Middle Eastern and African markets are expected to register a sluggish rate of growth over the forecast timeline, owing to the lack of advanced healthcare facilities, low product awareness, and poor living conditions.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/osteoarthritis-drug-market

Some major players of the global osteoarthritis drug market include Pfizer Inc., Horizon Pharma plc, Ferring B.V., Bioventus, Inc., Sanofi, Flexion Therapeutics, Inc., Alkem Laboratories, Anika Therapeutics, Inc., Chugai Pharmaceutical Co., Limited, and Zimmer Biomet Holdings, Inc., among others.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/3760

This report segments the global osteoarthritis drug market into:

Global Osteoarthritis Drug Market: Drug Class Analysis

  • Corticosteroids
  • NSAIDs
  • Viscosupplementation Agents 
  • Others

Global Osteoarthritis Drug Market: Route of Administration Analysis

  • Oral
  • Parenteral
  • Topical

Global Osteoarthritis Drug Market: Distribution Channel Analysis

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Osteoarthritis Drug Market: Regional Analysis

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Blog: http://usindustrynews.com | http://europeindustrynews.com | http://zmrresearchnews.us | http://zmrmarketjournal.com

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com